Large cohort studies of people with a first-episode psychosis provide a unique opportunity for finding out why so many young people with schizophrenia spectrum disorders die at a young age. However, it seems that those psychiatrists who have access to the mortality data generally do not want the facts to come out.

In Parts I-IV, I discuss how the DA succeeded in gaining the conviction by means of highly emotional and at times misleading and untruthful manipulations in public and in the courtroom. Here I want to look more closely at the DA’s motivation and other activities. Was it a personal vendetta?

A common practice when antipsychotics are found to be ineffective for schizophrenia is to prescribe a second, additional psychoactive medication. Now, a new study suggests that this practice is not supported by the research.